PeptiSystems, a life science company developing advanced manufacturing solutions for peptide and oligonucleotide-based therapeutics, has announced a significant growth investment from Rubicon Healthcare Partners. The partnership will enable PeptiSystems to accelerate its global expansion and deliver scalable, next-generation manufacturing solutions to a rapidly growing biopharma market. Uppsala, Sweden — Rubicon Healthcare Partners is a growth-oriented […]

Funding will accelerate commercialization of its breakthrough biomarker detection platform MUSE®. Oberkochen, Germany | ZEISS Group ZEISS Ventures participated in an oversubscribed financing round of CHF 6.3 million for arcoris bio, a Swiss start-up specializing in a platform technology aimed at enhancing biomolecule detection and imaging for spatial multiomics solutions. The funding round, co-led by […]

Spin-off positions Solstice to accelerate growth and unlock shareowner value as a leading pure-play specialty materials company Poised to benefit from strong and resilient secular trends across cooling, building solutions, advanced computing, energy, safety and healthcare Begins trading today on Nasdaq under the ticker symbol “SOLS” MORRIS PLAINS, N.J. — Solstice Advanced Materials (NASDAQ: SOLS), […]

Company Welcomes Dr. Chuck Mattera, former Chair and CEO of Coherent Corp as new Chairman ALEXANDRIA, VA – HyperSpectral, the world’s first AI-powered spectral intelligence company, today announced the close of a $7M Series A-2 capital raise. The round will fuel accelerated development, expand partnerships, and position the company for a Series B round in […]

Pharmacogenomics Workflow: Identifying Biomarkers and Treatment Options BOZEMAN, Mont. — Golden Helix, Inc. announced that it was awarded the NIH SBIR Grant 2R44HG013456-02 “Pharmacogenomics Workflow: Identifying Biomarkers and Treatment Options.” Pharmacogenomics is expanding clinicians’ ability to deliver personalized medicine, enabling drug selection, dosage, efficacy, and safety to be tailored to each patient’s unique biological needs. […]

Funding enables company to scale its DNA synthesis services to meet accelerating demand and empower scientists to innovate across medicine, agriculture, and beyond EMERYVILLE, Calif. — Ansa Biotechnologies, Inc., a trusted partner for DNA synthesis, today announced that it has closed $45.2 million and secured commitments for an additional $9.2 million as part of an […]

BARCELONA, Spain and SALT LAKE CITY and AUSTIN, Texas — DataJoint, a leading computational database and AI platform designed to streamline data management and accelerate research in neuroscience, oncology, and systems biology, today announced the successful closing of its $4.9M Seed funding round. The round was co-led by Barcelona-based Nina Capital, Salt Lake City-based Inoca […]

Synthesize Bio’s generative genomics models predict the results of gene expression experiments with unprecedented accuracy Funding led by Madrona with participation from AI2 Incubator, Sahsen Ventures, Inner Loop Capital and Point Field Partners Synthesize Bio is actively engaging with biopharma partners to enable more confident drug development decisions using generative genomics GEM-1 foundation model now […]

RiboMarker-NextGen Biomarker Discovery SANTA CRUZ, CA, UNITED STATES — RealSeq Biosciences, a pioneer in RNA-based diagnostics, today announced it has received a Phase II Small Business Innovation Research (SBIR) grant from the National Institutes of Health (NIH) (FAIN# R44HG013284; Federal Award Date: August 15, 2025). This highly competitive award provides multi-year, non-dilutive funding to accelerate […]

Genk (BE) — Aspect Analytics, a leading provider of software for spatial biology data analysis, announced the successful closing of an oversubscribed € 10 million Series A funding round. The investment will accelerate the company’s international expansion, support continued innovation, and reinforce its position as the leader in spatial multi-omic data integration and large-scale research […]